His bundle pacing after failure of cardiac resynchronization therapy: a case study
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu kazuistiky, časopisecké články
PubMed
32420781
PubMed Central
PMC7235673
DOI
10.1177/0300060520923495
Knihovny.cz E-zdroje
- Klíčová slova
- His bundle pacing, cardiac resynchronization therapy, cardiomyopathy, heart failure, left bundle branch block, left ventricular ejection fraction,
- MeSH
- blokáda Tawarova raménka diagnóza etiologie patofyziologie chirurgie MeSH
- dilatační kardiomyopatie komplikace diagnóza patofyziologie chirurgie MeSH
- elektrokardiografie MeSH
- funkce levé komory srdeční fyziologie MeSH
- Hisův svazek fyziologie MeSH
- implantované elektrody MeSH
- kardiostimulace umělá metody MeSH
- kardiostimulátor MeSH
- lidé MeSH
- senioři MeSH
- srdeční katetrizace přístrojové vybavení metody MeSH
- srdeční resynchronizační terapie škodlivé účinky MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
His bundle pacing is a relatively new method of cardiac pacing. This method is used in patients with atrioventricular block to prevent heart failure associated with right ventricular pacing, and in patients with bundle branch block and cardiomyopathy. We report a patient with cardiomyopathy and left bundle branch block with failure of cardiac resynchronization therapy. Permanent His bundle pacing was associated with clinical improvement and improvement of parameters of cardiac function.
Zobrazit více v PubMed
Narula OS, Scherlag BJ, Samet P. Pervenous pacing of the specialized conducting system in man: his bundle and A-V nodal stimulation. Circulation 1970; 41: 77–87. PubMed
Ali N, Keene D, Arnold A, et al. His bundle pacing: a new frontier in the treatment of heart failure. Arrhythm Electrophysiol Rev 2018; 7: 103–110. PubMed PMC
Vijayaraman P, Chung MK, Dandamudi G, et al. His bundle pacing. J Am Coll Cardiol 2018; 72: 927–947. PubMed
Cleland JG, Daubert JC, Erdmann E, et al. . The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539–1549. PubMed
Moss AJ, Hall JW, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329–1338. PubMed
Kubánek M, Málek I, Bytešník J, et al. Decrease in plasma B-type natriuretic peptide early after cardiac resynchronization therapy predicts clinical improvement at 12 months. Eur J Heart Fail 2006; 8: 832–840. PubMed
Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 2018; 391: 572–580. PubMed PMC
